PBH vs CHD

For growth investors, Church & Dwight Co.

, Inc. (CHD) is the stronger pick with 1. 6% revenue growth year-over-year, versus 1. 1% for Prestige Consumer Healthcare Inc. (PBH). Prestige Consumer Healthcare Inc. (PBH) offers the better valuation at 12. 7x trailing P/E (12. 0x forward), making it the more compelling value choice. Analysts rate Prestige Consumer Healthcare Inc. (PBH) a "Buy" — based on 17 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Prestige Consumer Healthcare Inc.

(PBH) is the cheapest at 12. 7x versus Church & Dwight Co. , Inc. at 31. 1x. On forward P/E, Prestige Consumer Healthcare Inc. is actually cheaper at 12. 0x.

Over the past 5 years, Prestige Consumer Healthcare Inc.

(PBH) delivered a total return of +18. 4%, compared to +13. 7% for Church & Dwight Co. , Inc. (CHD). Over 10 years, the gap is even starker: CHD returned +113. 6% versus PBH's -3. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Church & Dwight Co.

, Inc. (CHD) is the lower-risk stock at 0. 14β versus Prestige Consumer Healthcare Inc. 's 0. 53β — meaning PBH is approximately 285% more volatile than CHD relative to the S&P 500. On balance sheet safety, Church & Dwight Co. , Inc. (CHD) carries a lower debt/equity ratio of 55% versus 57% for Prestige Consumer Healthcare Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Church & Dwight Co.

, Inc. (CHD) is pulling ahead at 1. 6% versus 1. 1% for Prestige Consumer Healthcare Inc. (PBH). On earnings-per-share growth, the picture is similar: Church & Dwight Co. , Inc. grew EPS 27. 4% year-over-year, compared to 2. 9% for Prestige Consumer Healthcare Inc.. Over a 3-year CAGR, CHD leads at 4. 9% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Prestige Consumer Healthcare Inc.

(PBH) is the more profitable company, earning 18. 9% net margin versus 11. 9% for Church & Dwight Co. , Inc. — meaning it keeps 18. 9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: PBH leads at 29. 6% versus 17. 4% for CHD. At the gross margin level — before operating expenses — PBH leads at 55. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, Prestige Consumer Healthcare Inc.

(PBH) trades at 12. 0x forward P/E versus 25. 0x for Church & Dwight Co. , Inc. — 13. 0x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for PBH: 20. 9% to $66. 00.

In this comparison, CHD (1.

3% yield) pays a dividend. PBH does not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, Church & Dwight Co.

, Inc. (CHD) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 14), 1. 3% yield, +113. 6% 10Y return). Both have compounded well over 10 years (CHD: +113. 6%, PBH: -3. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (PBH (Healthcare) and CHD (Consumer Defensive)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: PBH is a small-cap deep-value stock; CHD is a mid-cap quality compounder stock. CHD pays a dividend while PBH does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.